MVITRO

MVITRO is a South Korean research and development company focused on creating innovative medical devices and healthcare platforms. The company specializes in home care and remote medical consultations, aiming to enhance health and extend lifespan through advanced technology solutions. One of its key products is ORTIV, a glucose meter that utilizes painless laser blood sampling for blood glucose monitoring. This device eliminates the need for traditional finger-prick needles, offering a pain-free and environmentally friendly alternative. ORTIV simplifies the blood glucose measurement process by combining a laser lancet and glucose meter into a compact design, and it integrates seamlessly with a mobile app for easy tracking of glucose levels. MVITRO is also developing AI-driven solutions for diabetes management, with plans to evolve into a comprehensive software and platform company. The company is pursuing FDA approval to enter the U.S. market and collaborates with major corporations to advance its medical device technologies. Its target customers include diabetic patients, healthcare providers, and corporate partners in the medical and pharmaceutical sectors.

• Employees 5